Related Experiment Videos
[Secondary prevention in HIV infection]
Therapeutische Umschau. Revue Therapeutique
|April 1, 1991
Summary
Secondary prophylaxis in HIV-positive individuals aims to prevent opportunistic diseases and slow HIV progression. Current strategies include vaccines and chemoprophylaxis, with antiretroviral therapy showing promise.
Area of Science:
- Infectious Diseases
- Immunology
- Virology
Context:
- HIV infection leads to secondary diseases from opportunistic pathogens.
- Controlling external transmission is less effective than managing endogenous microorganisms.
Purpose:
- To review secondary prophylaxis strategies for HIV-seropositive individuals.
- To discuss the role of vaccines, chemoprophylaxis, and antiretroviral therapy.
Summary:
- Vaccines for influenza, Streptococcus pneumoniae, and hepatitis B are available but may elicit suboptimal responses in immunocompromised individuals.
- Chemoprophylaxis is primarily used for Pneumocystis carinii pneumonia and tuberculosis prevention.
- Antiretroviral therapy, such as zidovudine, shows potential in delaying AIDS progression in asymptomatic HIV individuals with compromised immunity.
Impact:
- Informs clinical practice regarding the prevention of HIV-associated complications.
- Highlights the limitations of current prophylactic measures and the potential of new therapies.
- Emphasizes the need for effective strategies to manage opportunistic infections in HIV patients.